Transamerica Financial Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
WCA
PVM
VCM
NI
Transamerica Financial Advisors's HCAT Position: Q1 2026 in Review
Transamerica Financial Advisors opened a new position in Health Catalyst (HCAT) in Q1 2026: 43 shares worth $54. The stake represents ﹤0.01% of the portfolio and ranks #1867 among its holdings. This is a return to the name: Transamerica Financial Advisors previously reported a position in HCAT as recently as Q3 2025.
Transamerica Financial Advisors first reported a position in HCAT in Q3 2025 and has held it in 2 quarters since. The position peaked at $764 in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.
- Transamerica Financial Advisors held 43 shares of Health Catalyst worth $54 as of Q1 2026.
- Health Catalyst was a new Transamerica Financial Advisors position in Q1 2026.
- Health Catalyst made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #1867 holding.
- Transamerica Financial Advisors first reported a position in Health Catalyst in Q3 2025 and has held it in 2 quarters since.
- Transamerica Financial Advisors's Health Catalyst position peaked at $764 in Q3 2025.
- 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.
Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.